TABLE 1.

Detailed clinical information for each patient.

Patient ID	Gender	Age (y)	Smoking status	Pathology type	Tumor stage ¶	Chemotherapy drugs	Chemo-therapy cycle
P1	Female	59	Never-smoker	ADC	II/III	Pemetrexed + Carboplatin	4
P2	Male	57	Current smoker	ADC	II/III	Pemetrexed + Carboplatin	8
P3	Male	63	Current smoker	SCC	IV/IV	Gemcitabine + nedaplatin	4
P4	Female	64	Never-smoker	ADC	IV/IV	Pemetrexed + carboplatin	8
P5	Female	66	Never-smoker	ADC	II/IV	Pemetrexed + carboplatin	5
P6	Male	56	Current smoker	ADC	IV/IV	Pemetrexed + carboplatin	4
P7	Female	53	Never-smoker	ADC	III/III	Pemetrexed + carboplatin	4
P8	Male	52	Current smoker	ADC	III/III	Pemetrexed + carboplatin	4
P9	Male	58	Current smoker	SCC	III/IV	Gemcitabine + nedaplatin	4

^¶ Information before the forward slash (/) refers to the primary-tumor stage, and that after the forward slash (/) refers to the progressive-sample stage. ADC, adenocarcinoma carcinoma; SCC, squamous cell carcinoma; y, years.